Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
100 hedge funds and large institutions have $632M invested in Flexion Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 10 closing their positions.
130% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 10
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
46% more capital invested
Capital invested by funds: $434M → $632M (+$198M)
6% more funds holding
Funds holding: 94 → 100 (+6)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
11% less call options, than puts
Call options by funds: $7.24M | Put options by funds: $8.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$43.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8.94M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$5.56M |
| 4 |
Bank of New York Mellon
New York
|
+$3.59M |
| 5 |
ICM
Ionic Capital Management
New York
|
+$3.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
-$5.89M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.67M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.75M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$4.02M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.93M |
FLXN Hedge Fund Activity: Q1 2017 in Review
100 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2017, worth a combined $632M — up 46% from $434M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new FLXN positions and 10 closed out — a net gain of 13 holders — while 31 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock, adding an estimated $43.1M. The largest seller was Kingdon Capital Management, cutting an estimated $5.89M.
- 100 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2017, up from 94 in Q4 2016.
- Funds reported $632M of Flexion Therapeutics, Inc. stock for Q1 2017, up 46% quarter-over-quarter.
- 23 funds opened new Flexion Therapeutics, Inc. positions in Q1 2017 and 10 closed out, a net change of +13 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2017 was BlackRock, an estimated $43.1M added.
- The largest Flexion Therapeutics, Inc. seller in Q1 2017 was Kingdon Capital Management, an estimated $5.89M sold.
Based on aggregated 13F filings for Q1 2017.